Mark Pruzanski

2012

In 2012, Mark Pruzanski earned a total compensation of $3.3M as Chief Executive Officer and President at Intercept Pharmaceuticals, a 299% increase compared to previous year.

Compensation breakdown

Bonus$120,000
Non-Equity Incentive Plan$212,063
Option Awards$924,996
Salary$377,000
Stock Awards$1,674,506
Other$2,373
Total$3,310,938

Pruzanski received $1.7M in stock awards, accounting for 51% of the total pay in 2012.

Pruzanski also received $120K in bonus, $212.1K in non-equity incentive plan, $925K in option awards, $377K in salary and $2.4K in other compensation.

Rankings

In 2012, Mark Pruzanski's compensation ranked 2,071st out of 11,487 executives tracked by ExecPay. In other words, Pruzanski earned more than 82.0% of executives.

ClassificationRankingPercentile
All
2,071
out of 11,487
82nd
Division
Manufacturing
728
out of 4,253
83rd
Major group
Chemicals And Allied Products
163
out of 1,198
86th
Industry group
Drugs
94
out of 920
90th
Industry
Pharmaceutical Preparations
78
out of 700
89th
Source: SEC filing on April 12, 2013.

Pruzanski's colleagues

We found two more compensation records of executives who worked with Mark Pruzanski at Intercept Pharmaceuticals in 2012.

2012

David Shapiro

Intercept Pharmaceuticals

Chief Medical Officer

2012

Barbara Duncan

Intercept Pharmaceuticals

Chief Financial Officer

News

You may also like